BR112014031143A2 - método para quantificar células imunes em tecidos tumorais e suas aplicações - Google Patents

método para quantificar células imunes em tecidos tumorais e suas aplicações

Info

Publication number
BR112014031143A2
BR112014031143A2 BR112014031143A BR112014031143A BR112014031143A2 BR 112014031143 A2 BR112014031143 A2 BR 112014031143A2 BR 112014031143 A BR112014031143 A BR 112014031143A BR 112014031143 A BR112014031143 A BR 112014031143A BR 112014031143 A2 BR112014031143 A2 BR 112014031143A2
Authority
BR
Brazil
Prior art keywords
immune cells
tumor
tumor tissues
applications
analyzed
Prior art date
Application number
BR112014031143A
Other languages
English (en)
Other versions
BR112014031143B8 (pt
BR112014031143B1 (pt
Inventor
Milecnik Bernhard
Pagès Franck
Galon Jérôme
Original Assignee
Hopitaux Paris Assist Publique
Inst Nat Sante Rech Med
Univ Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopitaux Paris Assist Publique, Inst Nat Sante Rech Med, Univ Paris Descartes filed Critical Hopitaux Paris Assist Publique
Publication of BR112014031143A2 publication Critical patent/BR112014031143A2/pt
Publication of BR112014031143B1 publication Critical patent/BR112014031143B1/pt
Publication of BR112014031143B8 publication Critical patent/BR112014031143B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

resumo da patente de invenção para: “método para quantificar células imunes em tecidos tumorais e suas aplicações”. um método para avaliação de um número ou a densidade de células imunológicas em tecidos tumorais compreendendo as etapas que consistem em: a. fornecer uma ou mais lâminas imunocoradas de secção de tecido obtidas por um sistema de coloração de lâminas automatizado usando anticorpos que se ligam especificamente a antígenos (marcadores) expressos pelas células imunológicas. b. proceder à digitalização das lâminas da etapa a. pela captura de imagem alta resolução, pelo qual uma imagem digital de alta definição (4,6 mm / pixel ou melhor) da lâmina a ser analisada é obtida, c. detectar a porção de corte de tecido sobre a imagem digital d. analisar a porção da seção de tecido para a definição (i) do tumor (tc) e (ii) da margem invasiva do tumor (im), e. fornecer uma grade de referência de tamanho com unidades uniformemente distribuídas tendo uma mesma superfície, a dita grade sendo adaptada ao tamanho do tumor a ser analisado, e1. verificar a qualidade da immunocoloração, f. detectar e quantificar as células coradas de cada unidade em que o número ou a densidade de células imunológicas coradas de cada unidade é avaliada.
BR112014031143A 2012-06-14 2013-06-14 Método para quantificar células imunes em tecidos tumorais e suas aplicações BR112014031143B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2012001446 2012-06-14
IBPCT/IB2012/001446 2012-06-14
PCT/EP2013/062405 WO2013186374A1 (en) 2012-06-14 2013-06-14 Method for quantifying immune cells in tumoral tissues and its applications

Publications (3)

Publication Number Publication Date
BR112014031143A2 true BR112014031143A2 (pt) 2017-08-08
BR112014031143B1 BR112014031143B1 (pt) 2022-03-03
BR112014031143B8 BR112014031143B8 (pt) 2022-11-22

Family

ID=46881097

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014031143A BR112014031143B8 (pt) 2012-06-14 2013-06-14 Método para quantificar células imunes em tecidos tumorais e suas aplicações

Country Status (13)

Country Link
US (1) US10317408B2 (pt)
EP (1) EP2861986B1 (pt)
JP (1) JP6449765B2 (pt)
KR (1) KR102179848B1 (pt)
CN (1) CN104541167B (pt)
AU (1) AU2013276470B2 (pt)
BR (1) BR112014031143B8 (pt)
CA (1) CA2873278C (pt)
DE (1) DE13731071T1 (pt)
ES (1) ES2902879T3 (pt)
IL (1) IL235738B (pt)
SG (1) SG11201408107RA (pt)
WO (1) WO2013186374A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3111221B2 (en) 2014-02-24 2022-01-19 Ventana Medical Systems, Inc. Methods, kits, and systems for scoring the immune response to cancer by simultaneous detection of cd3, cd8, cd20 and foxp3.
WO2016034655A2 (en) * 2014-09-03 2016-03-10 Ventana Medical Systems, Inc. Systems and methods for generating fields of view
US11275080B2 (en) 2014-11-05 2022-03-15 The Regents Of The University Of California Methods for stratifying non-responders to therapies that block PD1/PDL1 axis
WO2016118832A1 (en) 2015-01-22 2016-07-28 University Of Massachusetts Cancer immunotherapy
US10705088B2 (en) * 2015-10-23 2020-07-07 Novartis Ag Method of scoring a sample comprising tumor tissue
PL3455631T3 (pl) * 2016-05-09 2021-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Sposoby klasyfikowania pacjentów z nowotworem litym
US11315240B2 (en) * 2016-05-18 2022-04-26 Hoffmann-La Roche Inc. System and method of tumor classification
EP3532984B1 (en) * 2016-10-27 2024-05-08 Koninklijke Philips N.V. Apparatus for determining cellular composition information in one or more tissue samples
US11459568B2 (en) 2016-10-31 2022-10-04 University Of Massachusetts Targeting microRNA-101-3p in cancer therapy
CN106846310A (zh) * 2017-01-19 2017-06-13 宁波江丰生物信息技术有限公司 一种基于免疫组化技术的病理辅助分析方法
WO2019020556A1 (en) * 2017-07-24 2019-01-31 Ventana Medical Systems, Inc. METHODS AND SYSTEMS FOR ASSESSING INFILTRAT OF IMMUNE CELLS IN TUMOR SAMPLES
US11814623B2 (en) 2018-01-30 2023-11-14 University Of Massachusetts Methods of treating a wound using epigenetic regulation
JP7411667B2 (ja) * 2019-02-05 2024-01-11 ヴェンタナ メディカル システムズ， インク． ステージｉｖの結腸直腸がんにおける免疫細胞浸潤の評価のための方法及びシステム
WO2020245155A1 (en) 2019-06-03 2020-12-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for modulating a treatment regimen
CN114556480A (zh) 2019-11-07 2022-05-27 欧森纳治疗股份有限公司 肿瘤微环境的分类
CN111551546B (zh) * 2020-06-01 2023-01-03 南京瑟斯检测科技有限公司 一种基于光学微腔结构超材料的免疫组化便捷检测方法
EP4172621A1 (en) 2020-06-30 2023-05-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
CN115843335A (zh) 2020-06-30 2023-03-24 国家医疗保健研究所 用于预测患有实体癌的患者在术前辅助治疗和根治性手术后复发和/或死亡风险的方法
CN113092202A (zh) * 2021-03-25 2021-07-09 上海福君基因生物科技有限公司 一种胃癌预后预测装置
CN113515077A (zh) * 2021-04-23 2021-10-19 重庆德方信息技术有限公司 人体细胞染色过程监控系统及方法
WO2023018085A1 (ko) * 2021-08-10 2023-02-16 주식회사 루닛 병리 슬라이드 이미지와 관련된 정보를 출력하는 방법 및 장치
WO2023175366A1 (en) 2022-03-17 2023-09-21 Veracyte Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
CN116646088B (zh) * 2023-07-27 2023-12-01 广东省人民医院 一种预测方法、装置、设备及介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6215892B1 (en) * 1995-11-30 2001-04-10 Chromavision Medical Systems, Inc. Method and apparatus for automated image analysis of biological specimens
EP1777523A1 (en) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
AU2006333078B2 (en) * 2005-12-19 2012-03-01 Ventana Medical Systems, Inc. Automated lean methods in anatomical pathology
CN102165489B (zh) * 2008-09-16 2015-11-25 赫斯托克斯公司 生物标志物表达的可再现量化
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Also Published As

Publication number Publication date
KR20150023760A (ko) 2015-03-05
EP2861986A1 (en) 2015-04-22
CA2873278C (en) 2021-10-26
ES2902879T3 (es) 2022-03-30
JP2015525349A (ja) 2015-09-03
WO2013186374A1 (en) 2013-12-19
US10317408B2 (en) 2019-06-11
IL235738A0 (en) 2015-01-29
CN104541167A (zh) 2015-04-22
EP2861986B1 (en) 2021-11-10
AU2013276470B2 (en) 2018-06-07
DE13731071T1 (de) 2016-08-18
US20150153349A1 (en) 2015-06-04
IL235738B (en) 2019-02-28
BR112014031143B8 (pt) 2022-11-22
CN104541167B (zh) 2018-05-01
AU2013276470A1 (en) 2014-11-27
CA2873278A1 (en) 2013-12-19
BR112014031143B1 (pt) 2022-03-03
KR102179848B1 (ko) 2020-11-17
SG11201408107RA (en) 2015-01-29
JP6449765B2 (ja) 2019-01-09

Similar Documents

Publication Publication Date Title
BR112014031143A2 (pt) método para quantificar células imunes em tecidos tumorais e suas aplicações
BR112018009071A8 (pt) método para preparar uma amostra, composição homogenizada, métodos para gerar dados, para tratar uma doença, de identificação de um marcador, para determinar o prognóstico de um câncer, para determinar um perfil fenotípico, para armazenar a composição homogenizada, para preparar uma amostra de tecido e preparar a composição homogenizada
BR112013009008A2 (pt) métodos e kits para a detecção de células circulantes de tumor em pacientes pancreáticos com o uso de reagentes de detecção de captura e de coquetel poliespecíficos
BR122018069446B8 (pt) método in vitro para detectar a presença de um célula de câncer em um indivíduo
BRPI0714332B8 (pt) aparelho de medição para enumeração de partículas em uma amostra, método para enumeração de partículas na amostra e meio legível de computador, para análise de uma amostra
BR112018006680A2 (pt) supressor contendo nanomaterial conjugado por polímero solúvel em água e uso do mesmo
BR112012015836A2 (pt) processo e sistema de formação de imagem por tomografia computadorizada, e, meio de armazenagem legível por computador
BR112013027125A2 (pt) método e sistema para analisar características de tecido, e, kit
BR112015014821A2 (pt) método e mídia legível por computador
WO2012110898A3 (en) System and method for multi-scanner x-ray inspection
MX2016002781A (es) Combinacion de formacion de imagenes de rayos x de energia multiple y datos de pozo para obtener perfiles de propiedades de la roca, mecanica y elastica de alta resolucion.
CL2020002768A1 (es) Métodos de diagnóstico de enfermedades mediante citometría de microflujos
Campo-Arias et al. The psychometric performance of the Perceived Stress Scale-10 on medical students from Bucaramanga, Colombia
BR112017021318A2 (pt) método implementado por computador, e mídia legível por computador
MX2015015015A (es) Metodo para diagnosticar cancer.
WO2012153964A3 (ko) 지질 프로파일을 이용한 비소세포성 폐암의 조직학적 분류를 위한 정보를 제공하는 방법
WO2014151079A8 (en) Ratio based biomarkers and methods of use thereof for the detection and prognosis of cancer
Sabino et al. Reliability analysis of the clinical application of the navicular drop test
Huang et al. Correlation between fundic gland polyps and colorectal neoplasia: a case? control study
IN2014DN10127A (pt)
UA123587U (uk) Спосіб кількісної оцінки відносної площі експресії маркерів при імуногістохімічному дослідженні тканин
Liu Prenatal screening for Down's syndrome: Recent progress
Zhang et al. Application and development of point-of-care testing in domain of tumor markers
HU et al. Meta Analysis of FCM DNA Ploidy in Distinguishing Benign Tumor from Malignant Ones
ES2521841B1 (es) Procedimiento de diagnóstico y pronóstico de la enfermedad renal crónica en un sujeto humano

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/06/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) ; ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR) ; UNIVERSITE DE PARIS (FR)

B25D Requested change of name of applicant approved

Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) ; ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR) ; UNIVERSITE PARIS CITE (FR)